echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > Nature Brainstem ADCYAP1+ neurons mediate pathological behavior

    Nature Brainstem ADCYAP1+ neurons mediate pathological behavior

    • Last Update: 2022-10-13
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Written by | Jun

    infection is one of the serious threats that organisms need to face in survival [1], while inducing immune cell responses, infection will also trigger a series of changes in the body, including anorexia, obesity, drowsiness, body temperature changes, etc.
    , which are collectively referred to as pathological behaviors [2, 3].

    。 If forced feeding or changing the ambient temperature increases mortality [4, 5], indicating that pathological behavior is an adaptive change made by the body in the face of infection, but the relevant neural mechanisms of pathological behavior have not been elucidated [6, 7], and it is not clear
    whether different pathological behaviors are controlled by the same neuron cluster.

    On September 7, 2022, the Jeffrey M.
    Friedman team at the Howard Hughes Medical Institute at Rockefeller University in New York published an article in the journal Nature Brainstem ADCYAP1+ neurons control multiple aspects of sickness behaviour , Explaining that endotoxin-induced pathological behavior is controlled by clusters of neurons expressing ADCYAP1 neuropeptide within the dorsal brainstem vagus complex, this paper identifies key nodes that link the immune response to the nervous system, providing a new perspective on the relationship between infection, inflammation, and behavior – the nervous system
    .


    The authors first induced the pathological behavior
    of mice by a single intraperitoneal injection of bacterial endotoxin lipopolysaccharide (LPS).
    The lethal dose of LPS is 10mg/kg, and three doses are selected in this article, namely 0.
    1, 0.
    5 and 2.
    5 mg/kg
    .
    The results of real-time monitoring showed that the pathological behavior showed a dose-dependent relationship, and the food intake, water intake, exercise ability, and body weight of the mice after LPS injection decreased rapidly, while the core temperature showed significant differences only in medium and high doses
    .
    Overall, the behavioral responses induced by the three doses are very similar, but higher doses of LPS result in longer durations
    .
    The effect of high doses at 48 hours after injection remains significant, the effect of medium doses can last for 24 hours, while the effects of low doses begin to disappear
    at 12 hours.
    Since the qualitative responses of the three doses were highly consistent, the authors chose to use the medium dose (0.
    5 mg/kg) to study the neural mechanisms
    of pathological behavior in later experiments.

    Using whole tissue embedded immunofluorescence staining technology and light film technology, the authors realized the expression observation
    of the whole brain, that is, early gene Fos after LPS injection.
    To identify key clusters of neurons that regulate the pathological effects, the authors chose to focus on brain regions that exhibit high expression of FOS early after LPS injection, namely the solitary bundle nucleus (NTS) and the posterior region (AP)
    located in the dorsal brainstem.
    Further use of the TRAP2 system to label LPS-activated neurons, and three weeks later, with the help of chemical genetic methods, the labeled neurons were reactivated, and it was found that their food intake, water intake, exercise capacity, body weight, and core temperature
    could be significantly reduced.
    In addition, if the activity of these neurons is suppressed before the re-injection of LPS, it is found that the pathological behavior that should have occurred is disturbed, and only the temperature is reduced
    as usual.
    These results suggest that activation of labeled neurons in NTS-AP brain regions is necessary for pathological behavior caused by LPS, while body temperature responses appear to be mediated
    by other brain regions.

    Next, the authors identified specific neuron types within NTS-AP that respond to LPS through single-cell nuclear RNA sequencing, and finally found that clusters of four types of excitatory neurons (expressing VGLUT2) and four groups of inhibitory neurons (expressing VGAT) changed
    after LPS injection.
    Activation of excitatory neurons within NTS-AP can induce significant pathological behavior, but activation of inhibitory neurons does not trigger pathological responses
    .
    Further regulating different clusters of excitatory neurons, the authors first focused on ADCYAP1+ neurons, which account for 65.
    45% of LPS-activated NTS neurons and 76.
    4%
    of AP neurons.
    The results showed that chemical genetics induced significant pathological behavior
    after activating ADCYAP1+ neurons.

    Since ADCYAP1+ neurons are distributed in both NTS and AP, in order to distinguish the different roles of the two brain regions, the authors also focus on DBH+ neurons, which coincide with ADCYAP1+ neuron clusters at APs up to 97.
    5%, while DBH+ neurons in NTS rarely respond
    to LPS.
    The results showed that activating DBH+ neurons induced weak pathological behavior, and the effect could only last for 6-12 hours, while the action of ADCYAP1+ neurons could last for 24 hours
    .
    The above results suggest that ADCYAP1+ neurons of NTS may play a more important role
    in pathological behavior.

    To study the ADCYAP1+ neurons of NTS, the authors also focused on PHOX2B+ neurons, which also coincide with ADCYAP1+ neuron clusters up to 97.
    5% at AP (the same neurons as DBH+), but are only expressed
    in NTS in some ADCYAP1+ neurons.
    Therefore, the role of ADCYAP1+ PHOX2B+ neurons in NTS can be obtained by comparing the roles of ADCYAP1+ neurons and PHOX2B+ neurons
    .
    The results also showed that activation of PHOX2B+ neurons induced weak pathological behavior, indicating that the pathological behavior was mainly controlled
    by ADCYAP1+PHOX2B-neurons within NTS.

    The results of inhibition of specific types of neurons by chemical genetics showed that inhibition of ADCYAP1+ neurons can interfere with LPS-induced pathological behavior, but inhibition of DBH+ neurons or PHOX2B+ neurons did not have an effect, indicating that these two types of neuron clusters that label almost all AP neurons are not necessary for pathological behavior, compared with ADCYAP1+ neurons, which have a key role in pathological behavior

    Taken together, this paper demonstrates that ADCYAP1+ neurons in NTS-AP are key agents in regulating LPS-induced pathological behavior, and this study has important implications
    for understanding how the immune system interacts with the nervous system.

    Original link:

    Maker: Eleven


    References


    1.
    Kent, S.
    , et al.
    , Sickness behavior as a new target for drug development.
     Trends In Pharmacological Sciences, 1992.
     13(1): p.
    24-28.

    2.
    Murray, M.
    J.
    and A.
    B.
    Murray, Anorexia of infection as a mechanism of host defense.
     The American Journal of Clinical Nutrition, 1979.
     32(3): p.
    593-596.
    3.
    Hart, B.
    L.
    , Biological basis of the behavior of sick animals.
     Neuroscience and Biobehavioral Reviews, 1988.
     12(2): p.
    123-137.
    4.
    Wang, A.
    , et al.
    , Opposing Effects of Fasting Metabolism on Tissue Tolerance in Bacterial and Viral Inflammation.
     Cell, 2016.
     166(6).
    5.
    Ganeshan, K.
    , et al.
    , Energetic Trade-Offs and Hypometabolic States Promote Disease Tolerance.
     Cell, 2019.
     177(2).
    6.
    Wang, Y.
    , et al.
    , A bed nucleus of stria terminalis microcircuit regulating inflammation-associated modulation of feeding.
     Nature Communications, 2019.
     10(1): p.
    2769.
    7.
    Carter, M.
    E.
    , et al.
    , Genetic identification of a neural circuit that suppresses appetite.
     Nature, 2013.
     503(7474): p.
    111-114.

    Reprint Notice

    【Original article】BioArt original article, welcome to share by individuals, without permission is prohibited to reprint, all published works are owned
    by BioArt.
    BioArt reserves all legal rights and violators will be prosecuted
    .

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.